How do you make conjoint market shares more accurate for use in forecast models?

Raw conjoint results used alone rarely reflect eventual market shares. We have discussed in a previous article how to transform conjoint preference shares into market shares using pharma-validated elasticities. In this article, we walk you through five evidence-based steps to transform conjoint market shares into more accurate eventual market shares.


Back to White Papers

Download the document by filling in the form:

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top